C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/01/2004	EP1482043A1 Proteins capable of binding to environmental hormones and process for producing the same
12/01/2004	EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1482039A1 PRESYNAPTIC PROTEIN p120
12/01/2004	EP1482038A1 Novel protein and dna thereof
12/01/2004	EP1482035A1 Process for producing physiologically active protein using genetically modified silkworm
12/01/2004	EP1482031A1 Serum-free mammalian cell culture medium, and uses thereof
12/01/2004	EP1481991A1 Allergenic protein of natural rubber
12/01/2004	EP1481990A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481988A2 Procedure to obtain and use antibiotic peptides for the treatment of infectious diseases
12/01/2004	EP1481986A1 Antibiotic 97518, pharmaceutically acceptable salts and compositions, and use thereof
12/01/2004	EP1481985A1 Modified hepatitis C virus (HCV) NS3 for medical treatment
12/01/2004	EP1481984A1 Modified hepatitis C virus (HCV) NS5
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481087A2 Zinc finger libraries
12/01/2004	EP1481085A2 Oligonucleotide analogues and methods of use for modulating gene expression
12/01/2004	EP1481081A2 Lipid-associated molecules
12/01/2004	EP1481070A2 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage
12/01/2004	EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
12/01/2004	EP1481065A2 Method for detection of leptin receptor ligands
12/01/2004	EP1481062A2 Expec-specific proteins, genes encoding them and uses thereof
12/01/2004	EP1481061A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
12/01/2004	EP1481060A2 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
12/01/2004	EP1481054A2 Il-10 gene transfer to peripheral mononuclear cells
12/01/2004	EP1481053A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
12/01/2004	EP1481011A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
12/01/2004	EP1481009A2 Peptides for use in antitumor immunotherapy
12/01/2004	EP1481008A2 Anti-amyloid beta antibodies and their use
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1481006A2 Universal antimicrobial treatment
12/01/2004	EP1481004A2 Streptavidin-binding peptide
12/01/2004	EP1481003A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
12/01/2004	EP1481001A2 Prion inhibiting peptides and derivatives thereof
12/01/2004	EP1480998A1 Intermediates and methods for making heptapeptide oxytocin analogues
12/01/2004	EP1480997A2 Haemophilus adherence and penetration proteins
12/01/2004	EP1480994A1 Neurotransmission-associated proteins
12/01/2004	EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
12/01/2004	EP1480672A2 Compositions and compounds for use as a nicotine vaccine employing response selective agonist of an antigen-presenting cell receptor as a molecular adjuvant
12/01/2004	EP1480671A2 Recombinant rsv virus expression systems and vaccines
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480514A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
12/01/2004	EP1351991A4 Ternary biomolecule/polymer/surface-based immobilization systems
12/01/2004	EP1212428B1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1176199B1 Tumor suppressor gene
12/01/2004	EP1173191A4 Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
12/01/2004	EP1119611A4 Method for the treatment of chemonucleolysis
12/01/2004	EP1082422B1 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/01/2004	EP1073745B1 Immunization against and treatment for infection by h. pylori
12/01/2004	EP1061793A4 Methods for improving seeds
12/01/2004	EP1012180B1 Hepatitis c inhibitor peptide analogues
12/01/2004	EP0961838A4 Reading frame independent epitope tagging
12/01/2004	EP0944837B1 Method for determining protein s
12/01/2004	EP0917571B1 Agouti-related gene
12/01/2004	EP0909320A4 CHEMOKINE beta-15
12/01/2004	EP0906448A4 Methods for the diagnosis and prognosis of cancer
12/01/2004	EP0895537B1 Iga1 protease fragment as carrier peptide
12/01/2004	EP0845540B1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
12/01/2004	EP0720650B1 Human metabotropic glutamate receptor subtype hmglur7 and related dna compounds
12/01/2004	EP0590048B1 A process for preparing therapeutic fragments of von willebrand factor
12/01/2004	EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
12/01/2004	CN1551920A Herbicide tolerant cotton plants and methods for producing and identifying same
12/01/2004	CN1551916A Seed specific 7Salpha promoter for expressing genes in plants
12/01/2004	CN1551915A DNA fragments containing gene having function relating to autonomous proliferation of plasmid
12/01/2004	CN1551913A Infectious bovine viral diarrhea virus clone and production method and use
12/01/2004	CN1551888A Modified human growth hormone
12/01/2004	CN1551886A Specific human antibodies for selective cancer therapy
12/01/2004	CN1551780A Oxynthomodulin for preventing or treating excess weight
12/01/2004	CN1550552A Clone of Chinese wildrye drought-resistant gene HVAI
12/01/2004	CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof
12/01/2004	CN1550549A Alpha-amylase mutants
12/01/2004	CN1550504A Process of high purity albumin production
12/01/2004	CN1550503A Gene BjCET1 of India nmustard cationic output transfer protein family and its protein
12/01/2004	CN1550502A Signal sequences for the production of Leu-hirudine via secretion by E. coli in a culture medium
12/01/2004	CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release
12/01/2004	CN1178062C Oligomercarrier molecules in which marker groups and haptens are selectively incorporated
12/01/2004	CN1177934C Adneovirus-mediated intratumoral delivery of angiogenesis antagonist for treatment of tumors
12/01/2004	CN1177933C Chrysosporium cellulase and methods of use
12/01/2004	CN1177927C Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgruop B
12/01/2004	CN1177864C Novel human protein with expression difference in liver cancer tissue and its coding sequence
12/01/2004	CN1177863C Attenuated microorganisms for treatment of infection
12/01/2004	CN1177862C Human NIP2 associated protein and coding sequence and application thereof
12/01/2004	CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
12/01/2004	CN1177613C Chemokine receptor antagonist and ocyclosporin in combined therapy
11/2004
11/30/2004	US6825398 Seed specific 7Sα promoter for expressing genes in plants
11/30/2004	US6825397 LEC1 trancriptional activator nucleic acids and methods of use thereof
11/30/2004	US6825395 Transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55)
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825334 Interleukin-2 (il-2) for drugs/drug screening; genetic engineering; mitogen-activated protein kinases (map-k)
11/30/2004	US6825333 EGFH2 genes and gene products
11/30/2004	US6825332 Gene related to migraine in man
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825326 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds
11/30/2004	US6825325 Fusion proteins; membrane anchoring; genetic engineering; kits
11/30/2004	US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004	US6825322 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/30/2004	US6825321 For breeding cold-avoidance plants; treatment of diabetes metllitus/obesity; development of thermogenic bio-materials

1 ... 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 ... 2916